Author Archives: Jason Carr

Analysts Conflicted on These Technology Names: Cisco Systems (NASDAQ: CSCO), Ouster (NYSE: OUST) and TELUS International (CDA) (NYSE: TIXT)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Cisco Systems (CSCO – Research Report), Ouster (OUST – Research Report) and TELUS International (CDA) (TIXT – Research Report). Cisco Systems (CSCO) In

CIBC Keeps a Buy Rating on Tucows (TCX)

CIBC analyst CIBC World Markets reiterated a Buy rating on Tucows (TCX – Research Report) yesterday and set a price target of C$70.00. The company’s shares closed last Monday at $79.85. Currently, the analyst consensus on Tucows is a Moderate

Analysts Offer Insights on Materials Companies: Verano Holdings (Other OTC: VRNOF) and RosCan Gold (Other OTC: RCGCF)

There’s a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Verano Holdings (VRNOF – Research Report) and RosCan Gold (RCGCF – Research Report) with bullish sentiments. Verano Holdings (VRNOF) In a report

H.C. Wainwright Reaffirms Their Hold Rating on Ziopharm Oncology (ZIOP)

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Hold rating on Ziopharm Oncology (ZIOP – Research Report). The company’s shares closed last Friday at $3.20. According to TipRanks.com, Ramakanth is a 5-star analyst with an average

H.C. Wainwright Sticks to Their Buy Rating for Calithera Bio (CALA)

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Calithera Bio (CALA – Research Report) today and set a price target of $4.00. The company’s shares closed last Friday at $2.09, close to its 52-week low of $2.03. According

H.C. Wainwright Maintains a Buy Rating on Puma Biotechnology (PBYI)

In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on Puma Biotechnology (PBYI – Research Report), with a price target of $15.00. The company’s shares closed last Friday at $9.79. According to TipRanks.com, White is